Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

Can-Fite BioPharma Ltd. CANF

Set alert

Price alert · CANF

All alert types
1.62 USD -0.04 -2.41%

At close · Oct 30

1.69 +0.07 +4.17%

After hours · Oct 30, 4:00 PM ET

Bid
1.60 × 100
Ask
1.69 × 800
1.60 Day range 1.70
1.62 52-week range 8.60
YTD
-59.50%
1 year
-81.16%
Open
1.68
Prev close
1.66
Mkt cap
4.91M
Vol
22.44K
Avg vol
376.27K
EPS
-13.23
P/E
0.00
Div yield
0.00%
More statistics
Low
1.60
High
1.70
Forward P/E
-2.00
Beta
0.57
Short ratio
1.96
Inst. own
8.02%
Dividend
0.00
Ex-div date
50-d avg
2.08
200-d avg
2.37
1y target
14.00

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for CANF has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-34.10 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C+2 / 5 overall

  • DCF 2
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 3

Valuation

P/E -49.9×
FY 2016: -11900×FY 2017: -11684×FY 2018: -11118×FY 2019: -2200×FY 2020: -4208×FY 2021: -4300×FY 2022: -4880×FY 2023: -3667×FY 2024: -4528×FY 2025: -49.9×
FY 2016 5y median -4300× FY 2025
P/S 1211×
FY 2016: 583262×FY 2017: 85476×FY 2018: 19247×FY 2019: 13952×FY 2020: 79670×FY 2021: 69396×FY 2022: 61433×FY 2023: 37851×FY 2024: 52623×FY 2025: 1211×
FY 2016 5y median 52623× FY 2025
P/B 88.4×
FY 2016: 25576×FY 2017: 23644×FY 2018: 24386×FY 2019: 11609×FY 2020: 10008×FY 2021: 4116×FY 2022: 11127×FY 2023: 4505×FY 2024: 6525×FY 2025: 88.4×
FY 2016 5y median 4505× FY 2025
P/FCF -54.8×
FY 2016: -11061×FY 2017: -7577×FY 2018: -17556×FY 2019: -2616×FY 2020: -5028×FY 2021: -5998×FY 2022: -4603×FY 2023: -3331×FY 2024: -4641×FY 2025: -54.8×
FY 2016 5y median -4603× FY 2025
EV/EBITDA -48.9×
FY 2016: -11393×FY 2017: -10076×FY 2018: -12002×FY 2019: -2364×FY 2020: -4302×FY 2021: -4614×FY 2022: -4935×FY 2023: -3438×FY 2024: -4366×FY 2025: -48.9×
FY 2016 5y median -4366× FY 2025
EV/Sales 1198×
FY 2016: 583214×FY 2017: 85472×FY 2018: 19246×FY 2019: 13951×FY 2020: 79659×FY 2021: 69391×FY 2022: 61429×FY 2023: 37845×FY 2024: 52616×FY 2025: 1198×
FY 2016 5y median 52616× FY 2025
FCF Yield -1.8%
FY 2016: -0.0%FY 2017: -0.0%FY 2018: -0.0%FY 2019: -0.0%FY 2020: -0.0%FY 2021: -0.0%FY 2022: -0.0%FY 2023: -0.0%FY 2024: -0.0%FY 2025: -1.8%
FY 2016 5y median -0.0% FY 2025

Profitability

Gross Margin 94.1%
FY 2016: 100.0%FY 2017: 100.0%FY 2018: 100.0%FY 2019: 100.0%FY 2020: 100.0%FY 2021: 100.0%FY 2022: 100.0%FY 2023: 100.0%FY 2024: 100.0%FY 2025: 94.1%
FY 2016 5y median 100.0% FY 2025
Operating Margin -2456.8%
FY 2016: -5093.7%FY 2017: -873.1%FY 2018: -141.7%FY 2019: -590.9%FY 2020: -1853.1%FY 2021: -1505.5%FY 2022: -1246.4%FY 2023: -1103.0%FY 2024: -1206.2%FY 2025: -2456.8%
FY 2016 5y median -1246.4% FY 2025
Net Margin -2426.7%
FY 2016: -4069.3%FY 2017: -588.2%FY 2018: -172.0%FY 2019: -621.3%FY 2020: -1892.9%FY 2021: -1476.6%FY 2022: -1255.9%FY 2023: -1027.5%FY 2024: -1169.1%FY 2025: -2426.7%
FY 2016 5y median -1255.9% FY 2025
ROE -177.1%
FY 2016: -178.4%FY 2017: -162.7%FY 2018: -217.9%FY 2019: -517.0%FY 2020: -237.8%FY 2021: -87.6%FY 2022: -227.5%FY 2023: -122.3%FY 2024: -145.0%FY 2025: -177.1%
FY 2016 5y median -145.0% FY 2025
ROIC -146.6%
FY 2016: -104.9%FY 2017: -122.2%FY 2018: -112.0%FY 2019: -243.1%FY 2020: -170.4%FY 2021: -72.9%FY 2022: -147.8%FY 2023: -102.5%FY 2024: -114.2%FY 2025: -146.6%
FY 2016 5y median -114.2% FY 2025
ROA -104.1%
FY 2016: -67.8%FY 2017: -63.4%FY 2018: -82.6%FY 2019: -154.5%FY 2020: -151.7%FY 2021: -62.2%FY 2022: -109.6%FY 2023: -76.4%FY 2024: -86.4%FY 2025: -104.1%
FY 2016 5y median -86.4% FY 2025

Growth (YoY)

Revenue -39.4%
FY 2016: 2.9%FY 2017: 398.4%FY 2018: 352.2%FY 2019: -46.8%FY 2020: -62.5%FY 2021: 11.8%FY 2022: -5.0%FY 2023: -8.3%FY 2024: -9.3%FY 2025: -39.4%
FY 2016 FY 2025
Operating Income -23.4%
FY 2016: -34.6%FY 2017: 14.6%FY 2018: 26.6%FY 2019: -121.8%FY 2020: -17.8%FY 2021: 9.2%FY 2022: 21.4%FY 2023: 18.8%FY 2024: 0.8%FY 2025: -23.4%
FY 2016 FY 2025
EPS (diluted) -1013.9%
FY 2016: -11.1%FY 2017: 36.7%FY 2018: 10.5%FY 2019: 11.8%FY 2020: 71.8%FY 2021: 35.0%FY 2022: 54.5%FY 2023: 52.0%FY 2024: 40.0%FY 2025: -1013.9%
FY 2016 FY 2025
Free Cash Flow -18.1%
FY 2016: -90.3%FY 2017: -6.6%FY 2018: 56.1%FY 2019: -158.8%FY 2020: -11.6%FY 2021: 18.4%FY 2022: -9.5%FY 2023: 21.9%FY 2024: 9.5%FY 2025: -18.1%
FY 2016 FY 2025

Financial Health

Current Ratio 3.5×
FY 2016: 4.0×FY 2017: 3.8×FY 2018: 2.5×FY 2019: 2.2×FY 2020: 7.4×FY 2021: 7.4×FY 2022: 3.7×FY 2023: 4.9×FY 2024: 4.4×FY 2025: 3.5×
FY 2016 5y median 4.4× FY 2025
Quick Ratio 3.5×
FY 2016: 4.0×FY 2017: 5.7×FY 2018: 3.8×FY 2019: 2.4×FY 2020: 7.4×FY 2021: 7.4×FY 2022: 3.7×FY 2023: 4.9×FY 2024: 4.4×FY 2025: 3.5×
FY 2016 5y median 4.4× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.5×
FY 2016: 0.9×FY 2017: 0.5×FY 2018: 0.6×FY 2019: 0.2×FY 2020: 0.6×FY 2021: 0.3×FY 2022: 0.3×FY 2023: 0.5×FY 2024: 0.6×FY 2025: 0.5×
FY 2016 5y median 0.5× FY 2025
Interest Coverage -711×
FY 2016: -316×FY 2017: -6.7×FY 2018: -4.5×FY 2019: -28.1×FY 2020: -39.0×FY 2021: -713×FY 2022: -131×FY 2023: -585×FY 2024: -581×FY 2025: -711×
FY 2016 5y median -585× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31